The patient with unstable angina: no evidence of MI
1Soroka Hospital, Beer Sheva, Israel.
Acta Diabetologica
|January 6, 2004
Insights
This study highlights the increased cardiovascular risk in type 2 diabetic women with metabolic syndrome. Optimal treatment involves percutaneous coronary intervention (PCI) and managing metabolic factors.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome Research
Background:
- Type 2 diabetes mellitus (T2DM) significantly increases cardiovascular disease (CVD) risk, particularly in women with metabolic syndrome.
- Macrovascular complications and metabolic derangements exacerbate CVD risk in this demographic.
- Understanding the interplay of gender, microvascular issues, and metabolic parameters is crucial for prognosis.
Observation:
- A 53-year-old woman with T2DM, metabolic syndrome, and macrovascular complications presented with unstable angina and ST depression.
- Her case underscores the heightened cardiovascular risk associated with female gender, microvascular complications, and specific metabolic parameters.
Findings:
- Hormone replacement therapy, antioxidant use, and universal folic acid supplementation lack robust evidence for improving cardiovascular outcomes in this context.
- Percutaneous coronary intervention (PCI) with stenting, anticoagulation (low molecular weight heparin), antiplatelet therapy (clopidogrel), and glycoprotein IIb/IIIa inhibitors are discussed as treatment options.
- Achieving optimal metabolic control is a critical component of managing cardiovascular risk.
Implications:
- The findings emphasize the need for personalized cardiovascular risk assessment and management strategies in diabetic women with metabolic syndrome.
- Current evidence does not support routine hormone replacement, antioxidant, or folic acid therapy for CVD prevention in this population.
- Aggressive management of metabolic syndrome components alongside guideline-directed medical therapy and revascularization is essential for improving outcomes.
Abstract:
A 53-year-old type 2 diabetic woman with macrovascular complications as well as the components of the metabolic syndrome presents with an unstable angina and ST depression on electromiogram. The negative impact of female gender, microvascular complications, and metabolic parameters on cardiovascular risk and prognosis, are emphasized. The lack of evidence for hormone replacement, antioxidant or universal folic acid therapy is underscored. Treatment options including PTCA and stenting augmented with low molecular weight heparin, clopidrogel and IIb/IIIa antagonists as well as optimal metabolic control are discussed.
Related Concept Videos
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
01:27Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
01:29Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...